Empagliflozin and progression of kidney disease in type 2 diabetes

EMPA-REG OUTCOME Investigators

Research output: Contribution to journalArticlepeer-review

1694 Scopus citations

Fingerprint

Dive into the research topics of 'Empagliflozin and progression of kidney disease in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences